Bronchial asthma: is personalized therapy on the horizon? - Wikidata - awgldk - TriplyDB

Bronchial asthma: is personalized therapy on the horizon?

Bronchial asthma: is personalized therapy on the horizon?

http://www.wikidata.org/entity/Q35777120

about

Role of the TSLP/DC/OX40L pathway in asthma pathogenesis and airway inflammation in mice.Nordic consensus statement on the systematic assessment and management of possible severe asthma in adults.

P2860

Q50099445-3DC3C237-724D-44CF-BBFF-F323E821A476 Q52657068-AAB54972-1A83-4765-8200-7C57E202B498

P2860

Bronchial asthma: is personalized therapy on the horizon?

http://www.wikidata.org/entity/Q35777120

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Bronchial asthma: is personalized therapy on the horizon?

@ast

Bronchial asthma: is personalized therapy on the horizon?

@en

type

label

Bronchial asthma: is personalized therapy on the horizon?

@ast

Bronchial asthma: is personalized therapy on the horizon?

@en

prefLabel

Bronchial asthma: is personalized therapy on the horizon?

@ast

Bronchial asthma: is personalized therapy on the horizon?

@en

P1433

Q35777120-248C4525-E68E-4752-87D5-B7F2DBB9B6C8

P1476

Q35777120-6727BD79-8E24-458D-99D1-F99F8983DBA1

P2093

Q35777120-742913E7-3FBE-4D3D-887E-C7F5C081EED5

P2860

Q35777120-0149D56D-B9B6-4AA4-BA89-BD551543BA1E

Q35777120-0747DB3B-BD32-40B6-9F87-32FBC07923C0

Q35777120-0BAD4DAF-CC9A-4928-B7B8-9D7BB5A3F90F

Q35777120-0C88E247-B1AC-4D78-A50B-99D9401D8906

Q35777120-10CDF743-200D-4B29-BBAF-C23D69EF8335

Q35777120-1CFEC6C0-1AC9-47E7-B7DF-2FEFAFF0255C

Q35777120-2524090A-E3E3-43D8-B7B5-03858561DE72

Q35777120-2710CFB8-75AA-47AB-A8DB-9E614BC3A4E6

Q35777120-39E07373-2421-4293-B7BD-6DA83BBC4E06

Q35777120-46BA3925-4BE7-4DAB-B3C6-56673D148016

P2888

Q35777120-0279F0F9-3A21-4F2A-B2F5-DA052CB28B30

P304

Q35777120-20B400C7-DF95-4DD2-8DAB-3B19FB19D458

P31

Q35777120-9175EECC-DE78-4DC8-AA7B-212560B6BEB8

P356

Q35777120-B31F48DA-C8AB-4F04-BBA6-25E92022DA44

P433

Q35777120-EF5F8F7C-8600-4A12-B070-9C6FD60A2D06

P478

Q35777120-12A1BE9C-9DCD-4C25-B0FB-8D7F96074B64

P50

Q35777120-E2DBF476-9696-4AA1-BAB2-21785A06F88F

P577

Q35777120-49886CF9-38EB-4B4F-86D1-B7572CC452B6

P5875

Q35777120-5704EC9D-84EB-400A-ACBA-6555BB30C16A

P698

Q35777120-A8CD64BD-C955-4FFE-B3A2-1A7FD37DE890

P921

Q35777120-BD18178C-6E28-4FFD-8679-5EC6AC51CCF2

P932

Q35777120-F16DD5C5-26EC-4FAB-AE32-77DE71126804

P356

S40629-014-0028-Y

P1433

Allergo journal international

P1476

Bronchial asthma: is personalized therapy on the horizon?

@en

P2093

Christian Taube

http://www.w3.org/2001/XMLSchema#string

P2860

Folate and asthma.

Reslizumab for Poorly Controlled, Eosinophilic Asthma

Lebrikizumab treatment in adults with asthma.

Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia.

Against all odds: anti-IgE for intrinsic asthma?

Randomized, double-blind, placebo-controlled study of brodalumab, a human anti-IL-17 receptor monoclonal antibody, in moderate to severe asthma.

OX40L blockade and allergen-induced airway responses in subjects with mild asthma

Treatment of patients with the hypereosinophilic syndrome with mepolizumab.

Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children.

Effects of omalizumab on markers of inflammation in patients with allergic asthma.

P2888

s40629-014-0028-y

P304

246-251

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40629-014-0028-Y

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P50

Christian Taube

P577

2014-11-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281846692

http://www.w3.org/2001/XMLSchema#string

P698

26120534

http://www.w3.org/2001/XMLSchema#string

P921

P932

4479476

http://www.w3.org/2001/XMLSchema#string